Filing Details

Accession Number:
0001144204-17-026585
Form Type:
4
Zero Holdings:
No
Publication Time:
2017-05-11 20:56:53
Reporting Period:
2017-05-09
Filing Date:
2017-05-11
Accepted Time:
2017-05-11 20:56:53
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1133869 Capricor Therapeutics Inc. CAPR Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1269910 Center Medical Sinai Cedars 8700 Beverly Blvd
Beverly Hills CA 90048
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2017-05-09 1,145,161 $3.10 4,049,959 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Footnotes
  1. The Reporting Person entered into a Subscription Agreement with Capricor Therapeutics, Inc. (the "Issuer") pursuant to which the Reporting Person, on May 5, 2017 purchased an aggregate of 1,145,161 shares of the Issuer's common stock at a purchase price of $3.10 per share for total cash proceeds of approximately US$3,550,000.